What is Rydapt used to treat?
Medically reviewed by Judith Stewart, BPharm. Last updated on Dec 16, 2020.
Official Answer
by Drugs.comRydapt (midostaurin) is an oral, multi-targeted kinase inhibitor used to treat acute myeloid leukemia (AML) and systemic mastocytosis.
Rydapt is used in the treatment of newly diagnosed adult AML patients who have a specific genetic mutation called FLT3. The FLT3 mutation is detected in blood or bone marrow samples with a diagnostic called the LeukoStrat CDx FLT3 Mutation Assay. Rydapt is used in combination with the chemotherapy medicines cytarabine and daunorubicin.
Rydapt is also used in adults with certain types of rare blood disorders (aggressive systemic mastocytosis, systemic mastocytosis with associated hematological neoplasm or mast cell leukemia).
Related Medical Questions
- Is Venclexta (venetoclax) chemotherapy?
- How long do you take Venclexta for?
- How effective is Venclexta?
- How is Venclexta (venetoclax) used for AML?
- How does Venclexta work?
- What type of cancer is Daurismo (glasdegib) used to treat?
- What type of leukemia is Xospata (gilteritinib) used to treat?
- What is Tibsovo used to treat?
- What is Idhifa used to treat?
Drug Information
- Rydapt Information for Consumers
- Rydapt Information for Healthcare Professionals (includes dosage details)
- Side Effects of Rydapt (detailed)
Related Support Groups
- Rydapt (1 questions, 3 members)
- Acute Myeloid Leukemia (11 questions, 21 members)
- Systemic Mastocytosis (6 questions, 7 members)